SGHT — Sight Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1531177 ·
Last close
$5.26
Market Cap
$286.20M
52W High
$5.89
52W Low
$4.09
ADV30
189,573
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 19,698,000 | 16,978,000 | -12,413,000 | -12,980,000 | 109,702,000 | 84,962,000 | 55,799,000 |
| Dec 2025 | 20,385,000 | 17,788,000 | -3,669,000 | -4,162,000 | 115,300,000 | 91,965,000 | 51,358,000 |
| Sep 2025 | 19,906,000 | 17,197,000 | -7,905,000 | -8,169,000 | 116,256,000 | 92,373,000 | 51,966,000 |
| Jun 2025 | 19,564,000 | 16,587,000 | -11,667,000 | -11,941,000 | 121,971,000 | 101,500,000 | 51,959,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-29,694,000
Investing CF
$-224,000
Financing CF
$1,791,000
CapEx
$-358,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.75
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-384,723,000
Inventory
$7,767,000
Receivables
$9,745,000
ST Investments
—
EBIT TTM
$-33,274,000
Pretax Income TTM
$-38,416,000
Interest Exp TTM
$5,142,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$79,553,000
EBITDA
$-27,012,000
Free Cash Flow
$-8,579,000
Enterprise Value
$242,995,296
Total Cash
$84,962,000
Total Debt
$41,761,000
Shares Out
54,409,942
Trailing EPS
$-0.70
Book Value
$1.00
ROE
-56.6%
ROA
-14.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 77,363,000 | -37,099,000 | -38,426,000 | 115,300,000 | 51,358,000 | — | -29,694,000 |
| Dec 2024 | 79,866,000 | -50,532,000 | -51,507,000 | 142,839,000 | 55,316,000 | — | -22,351,000 |
| Dec 2023 | 81,056,000 | -57,274,000 | -55,547,000 | 166,651,000 | 46,436,000 | — | -47,184,000 |
| Dec 2022 | 71,331,000 | -83,954,000 | -86,242,000 | 213,073,000 | 52,997,000 | — | -75,965,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.45
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $279.60M | $4.31 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $278.84M | $4.05 | — |
| TLSI | TriSalus Life Sciences, Inc. | $278.83M | $4.54 | — |
| PROF | Profound Medical Corp. | $268.17M | $7.38 | — |
| SMTI | Sanara MedTech Inc. | $311.28M | $33.86 | — |
News headlines (Yahoo Finance, 1h cache)
Integra LifeSciences (IART) Q2 Earnings Top Estimates
2026-07-29 11:30 · Yahoo
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-22 20:05 · Yahoo
Discover 3 Promising Penny Stocks With Market Caps Over $20M
2026-06-09 12:05 · Yahoo
Sight Sciences Q1 Earnings Call Highlights
2026-05-07 05:12 · Yahoo
Sight Sciences, Inc. Q1 2026 Earnings Call Summary
2026-05-07 00:35 · Yahoo
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
2026-05-06 23:30 · Yahoo
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates
2026-05-06 22:30 · Yahoo
Sight Sciences (SGHT) Q1 2026 Earnings Transcript
2026-05-06 22:25 · Yahoo
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
2026-05-06 20:05 · Yahoo
Sight Sciences to Present at Two Upcoming Investor Conferences
2026-04-29 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.